Viral dark matter exposed: metagenome database detects phage-derived antibacterial enzyme

Scientists demonstrate that the information about host bacteria–bacteriophage (phage) associations derived from world’s first metagenome analysis is useful for the development of phage therapies against intestinal pathobionts.

Thanks to phage, the system to fight bacteria is running smoothly.

Abnormalities in human intestinal microflora, known as dysbiosis, are connected to various diseases. Altered microbial diversity impairs the beneficial effects of host intestinal microflora, which cause some symbiotic commensal bacteria to acquire virulence traits, proliferate, and become directly involved in the development of disease. These bacteria are referred to as “pathobionts”, which are distinct from opportunistic pathogens.

C. difficile, which is a Gram-positive, spore-forming anaerobic bacterium, is a pathobiont and the representative cause of nosocomial diarrhea following antibiotic treatment. Since antibiotic usage has the risk of killing beneficial bacteria and promoting dysbiosis, the development of methods to specifically manipulate intestinal pathobionts is essential.

“Phages were sure to be applicable as a highly specific therapy for intestinal pathobiont elimination”, believed Professor Satoshi Uematsu. The infectious associations between phages and bacteria in the human intestine is essential information for the development of phage therapies. Known as “viral dark matter” as they had yet to be understood, researchers obtained metagenome information about bacteria-phage associations from the fecal samples of 101 healthy individuals through the development of a virome analysis pipeline. Based on this information, researchers screened C. difficile-specific phages and identified novel antibacterial enzymes, both in vitro and in vivo.

“The accumulation of more metagenomic information on intestinal phages and bacteria will open up the possibility of developing treatments for a variety of dysbiosis-related diseases”, say Dr. Kosuke Fujimoto and Prof. Seiya Imoto.

Published: 10 Jul 2020

Institution:

Contact details:

Rina MATSUKI

Osaka City University
3-3-138 Sugimoto
Sumiyoshi-ku, Osaka
558-8585 Japan

Country: 
News topics: 
Content type: 
Reference: 

Uematsu, Satoshi et al.: "Metagenome Data on Intestinal Phage-Bacteria Associations Aids the Development of Phage Therapy Against Pathobionts"
URL: https://doi.org/10.1016/j.chom.2020.06.005

Funding information:

the Takeda Science Foundation, the Canon Foundation, strategic programs for innovative research field 1 from Ministry of Education, Culture, Sports, Science and Technology of Japan, the Center of Innovation Program from Japan Science and Technology Agency